Digbei.com on March 27, Shanda Huate (000915) recently released its 2020 annual report. During the reporting period, the company achieved an operating revenue of 1821033958.04 yuan, a year-on-year increase of 1.17%; the net profit attributable to shareholders of listed companies was 290756639.28 yuan, a year-on-year increase of 42.46%.
During the reporting period, the net cash flow from operating activities was 735551506.32 yuan, and the net assets attributable to shareholders of listed companies were 1952595837.52 yuan by the end of 2020.
In the case of epidemic situation, the company firmly confidence in development, adhere to achieve the budget target unswervingly, overcome the impact of the epidemic, and do a good job in operation and management. In 2020, the company’s main business income is 1.821 billion yuan, and the net profit attributable to shareholders of listed companies is 291 million yuan, which is 1.17% and 42.46% higher than that in 2019, respectively. The company’s performance reaches a new record.
Daye pharmaceutical actively responded to the impact of the epidemic situation and changes in industrial policies, changed crisis into opportunity, promptly and decisively adjusted its business strategy, gave full play to the advantages of the rich variety of Uyghur and mineral products, and achieved good communication effect through the category education with “immunity” as the core; constructed and continuously improved the digital marketing system, carried out academic promotion activities and product publicity through the Internet, and promoted marketing Sales are more three-dimensional and flexible; positive progress has been made in the construction of production base, the intelligent and automatic level of production has been continuously improved, the production capacity has been continuously expanded, and the production conditions have been continuously improved. During the epidemic period, production has been persisted, and the market supply has been fully guaranteed; continuous market image construction has established a good reputation in the eyes of consumers, and the influence of the industry has been increasingly enhanced, and the market will continue to grow in 2020 The company won many honors such as “top 100 comprehensive strength of Chinese chemical pharmaceutical industry enterprises” and “excellent OTC product brand of Chinese chemical pharmaceutical industry in 2020”, adding a new chapter to brand building. In 2020, dyne pharmaceutical has fully completed various business indicators, achieved excellent business performance, and made outstanding contributions to the growth of Shanda Huate’s performance. The annual operating revenue is 1.124 billion yuan, an increase of 4.7% compared with that in 2019 (the comparable caliber is increased by 16.88%), and the net profit is 500 million yuan, an increase of 59.99% compared with that in 2019.
In 2020, the company’s environmental protection business achieved a total operating revenue of 349 million yuan, up 3.22% year on year. The impact of the epidemic on engineering projects is greater than that of general industries. The company’s environmental protection business overcame many difficulties and realized adverse growth. The environmental protection engineering company is committed to doing high-quality and high-quality projects, implementing the established policy of “rooted in Shandong and going to the whole country”, taking the initiative to achieve zero business breakthrough in Hebei, Fujian and other provinces and regions, and has achieved good economic benefits; the environmental protection branch’s concept of “Intelligent Collaborative disinfection” is expanding in the industry, and has been awarded the title of “environmental protection equipment manufacturing bank” by the Ministry of industry and information technology of the people’s Republic of China At the same time, it actively innovates and transforms. In the case of shrinking market of traditional chlorine dioxide generator, ozone generator and sodium hypochlorite generator become new performance support. The environmental protection science and technology division strengthens market development, early intervention of important projects and full service, which improves the bid winning rate, ecological management and environmental protection Sewage treatment and other businesses showed strong development potential.
During the period, the sales expenses were 277534067.72 yuan, a year-on-year decrease of 37.65%, which was mainly due to the implementation of the new revenue standard. The sales rebate originally included in the sales expenses directly offset the sales income. At the same time, due to the significant impact of the epidemic situation, the marketing activities, especially the promotion of new products, were greatly reduced. During the period, the R & D cost was 95886988.67 yuan, an increase of 47.34% over the same period last year, which was mainly due to the increase of R & D cost of the company’s subsidiary Dayin pharmaceutical undertaking the “national 13th five year plan new drug innovation” project.
During the period, the financial expenses were -8202653.67 yuan, a year-on-year decrease of 131%, mainly due to the increase of interest income in the current period. During the period, the investment income was 18218140.14 yuan, up from 13074436.47 yuan in the same period of last year, with a year-on-year increase.
According to the announcement, the total remuneration of directors, supervisors and senior managers during the reporting period was 11.2764 million yuan. Yao Guangping, the director and general manager, received a total pre tax remuneration of 1.0483 million yuan from the company, Wang Qingxiang, the financial director, received a total pre tax remuneration of 885000 yuan from the company, and fan Zhisheng, the Secretary of the board of directors, received a total pre tax remuneration of 803900 yuan from the company.
According to the announcement, the company’s profit distribution plan approved by the board of directors is as follows: Based on the total share capital of 234331485 shares as of December 31, 2020, cash dividends of 3.5 yuan (tax included) will be distributed to all shareholders for every 10 shares, and the capital will not be increased from the accumulation fund.
According to digbei.com, with the mission of “clearer water, bluer sky, more beautiful environment and healthier human beings”, Shanda Huate focuses on medicine and environmental protection. Other businesses involve education, new materials, information and other fields.